September 11, 2007: London, UK & Dublin, Ireland -- Alltracel Pharmaceuticals Plc., (“Alltracel "), (AIM:AP.L), the Healthcare Innovation Group focused on the Oral Care, Wound Care, Cardiovascular Health and Dermal Health markets, today announces interim financial results for the six months ended June 30th, 2007.
2007 First Half (H1 2007) Financial Highlights: Last years profitability growth continues into the first half of 2007.
Operating profit of €387k versus €71k in H1 2006 EBITDA of €592k versus €360k in H1 2006 Gross margin increased to 40% versus 36% in H1 2006 Revenue of €10.1M versus €9.5M in H1 2006 Closing cash balance of €2.3M.
